Meanwhile, we are all feeling the enormous impact that the corona pandemic is having on the clinical research industry. Conferences have been cancelled, travel restrictions are increasing, and there are additional obstacles for study patients undergoing treatment. At the latest since the school and daycare centre closures, all companies have had to reorganise. The primary goal is to slow down the spread of the virus as much as possible and to support our health system in treating those affected safely.
We are very aware of our duty of care towards our patients and employees and their safety is our top priority! In order to continue to ensure this, we have implemented a plan of action which regulates the work and handling of patients at our study centres with immediate effect. This enables us to maintain the study operation (in a minimized form):
Let us work together to find solutions to cope with the current situation. That is why it is all the more important in times like these to stay in touch and to support each other. If we can make a contribution in any way for you as a client, please do not hesitate to contact us:
Axel Nordhoff | Manager for Cooperation and Development: email@example.com
Dr. Ole Dammann (CEO)
Our structure comprising outpatient research sites with associate medical specialists and clinics enables us to map a broad range of clinical trial indications.